Corpus Intelligence IC Memo — PHELPS COUNTY REGIONAL MEDICAL CNTR 2026-04-26 06:41 UTC
IC Memo — PHELPS COUNTY REGIONAL MEDICAL CNTR
Investment Committee Memorandum | MO | 196 beds | Grade C | EBITDA uplift $19.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PHELPS COUNTY REGIONAL MEDICAL CNTR

CCN 260017 | PHELPS, MO | 196 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PHELPS COUNTY REGIONAL MEDICAL CNTR is a 196-bed suburban community hospital in PHELPS, MO with $270.3M in net patient revenue and a 33.1% operating margin. The hospital serves a payer mix of 33.6% Medicare, 14.8% Medicaid, and 51.6% commercial.

Thesis: Turnaround. Our ML models identify $19.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 33.1% to 40.4% (+736bps).

Net Revenue HCRIS$270.3M
Current EBITDA COMPUTED$89.4M
Operating Margin COMPUTED33.1%
Occupancy HCRIS38.8%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS22.4%
Distress Probability ML52.8%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
43
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of 33.1% places it above the state median. Among 43 size-comparable peers (98-392 beds), the median margin is -3.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (98-392), prioritizing same-state peers. 43 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PHELPS COUNTY REGIONAL MEDICAL (Target)MO196$270.3M33.1%
CHILDRENS MERCY HOSPITALMO328$1.44B30.5%
SSM SAINT LOUIS UNIVERSITY HOSMO317$772.2M-6.4%
HEARTLAND REGIONAL MEDICAL CENMO352$676.9M-6.2%
NORTH KANSAS CITY HOSPITALMO383$601.5M7.7%
FREEMAN OAK HILL HEALTH SYSTEMMO363$587.5M3.0%
ST. LUKES HOSPITALMO390$573.7M2.8%
SAINT FRANCIS MEDICAL CENTERMO282$556.6M-1.3%
UNIVERSITY HEALTH TRUMAN MED CMO258$540.8M-13.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.7M+210bp18mo
Cost to Collect4.5%2.5%$5.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.3M+122bp9mo
Clean Claim Rate88.0%96.0%$173K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.7M
Cost to Collect
$5.4M
Denial Rate Reduction
$5.4M
A/R Days Reduction
$3.3M
Clean Claim Rate
$173K
Total EBITDA Uplift$19.9M
Current EBITDA$89.4M
+ RCM Uplift+$19.9M
Pro Forma EBITDA$109.3M
Current Margin33.1%
Pro Forma Margin40.4%
WC Released (1x)$10.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$137.5M$788.6M5.73x41.8%
Base (11x exit)10.0x11.0x$137.5M$912.2M6.63x46.0%
Bull Case9.0x11.0x$123.8M$1.02B8.26x52.5%
Bull (12x exit)9.0x12.0x$123.8M$1.15B9.31x56.2%
Bear Case11.0x10.0x$151.3M$644.5M4.26x33.6%
Bear (11x exit)11.0x11.0x$151.3M$758.1M5.01x38.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 52.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 43 hospitals with 98-392 beds
  • Same-state prioritization (n=44)
  • Comp margins: P25=-16.5% / P50=-3.2% / P75=2.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.